Project Name ：Ramelteon
Registration Classification：3.1
Formulations and specifications ：Tablets: 8mg
Indications：Mainly for the treatment of insomnia, having difficulty in falling asleep, chronic insomnia with fewer adverse reactions, long-term medication does not produce drug dependence. Suitable for the elderly, especially suitable for those with poor sleep quality, insomnia and jet lag.
Original Research Company：Japan's Takeda
Progress：Has been reported to the State Council , the admissibility number : CXHL1400250; CXHL1400251
Category ：Nervous System Drugs